Qiagen NV (XTER:QIA) Additional Paid-In Capital : €1,756 Mil(As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Additional Paid-In Capital?

Qiagen NV's quarterly additional paid-in capital increased from Jun. 2023 (€1,744 Mil) to Sep. 2023 (€1,783 Mil) but then stayed the same from Sep. 2023 (€1,783 Mil) to Dec. 2023 (€1,756 Mil).

Qiagen NV's annual additional paid-in capital increased from Dec. 2021 (€1,609 Mil) to Dec. 2022 (€1,763 Mil) but then declined from Dec. 2022 (€1,763 Mil) to Dec. 2023 (€1,756 Mil).

Qiagen NV Additional Paid-In Capital Historical Data

The historical data trend for Qiagen NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Additional Paid-In Capital Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,599.32

1,507.69

1,609.38

1,763.41

1,756.16

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															1,763.41	1,757.94	1,744.49	1,783.19	1,756.16

Qiagen NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Qiagen NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (XTER:QIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » Additional Paid-In Capital

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (XTER:QIA) Headlines

No Headlines